Legend Biotech Stock (NASDAQ:LEGN), Quotes and News Summary

Q: What sector and industry does Legend Biotech (LEGN) operate in?

Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Legend Biotech Stock (NASDAQ: LEGN) stock price, news, charts, stock research, profile.

Open	$47.120
Close	$46.190
Volume / Avg.	1.254M / 1.004M
Day Range	45.680 - 47.300
52 Wk Range	47.085 - 77.320
Market Cap	$8.402B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	21
Short Interest	10.58%
Days to Cover	9.7

Recent News

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel

Vandana Singh

Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population

FDA approves Johnson & Johnson's Carvykti, a BCMA-targeted therapy for relapsed or refractory multiple myeloma patients, offering hope with increased manufacturing capacity and extended collaboration efforts.

Vandana Singh

GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy

Key Takeaways: GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary gained traction Legend’s Carvykti is expected to hit annual production capacity of 10,000 doses by the end of 2025 By Li Shih Ta

The Bamboo Works

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Legend Biotech Corp

Sector

Health Care

Industry

Biotechnology

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Legend Biotech (LEGN) stock?

You can purchase shares of Legend Biotech (NASDAQ: LEGN) through any online brokerage.

View our list of the best stock brokerages.

Who are Legend Biotech's (LEGN) competitors?

Other companies in Legend Biotech’s space includes: Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Roivant Sciences (NASDAQ:ROIV).

What is the target price for Legend Biotech (LEGN) stock?

The latest price target for Legend Biotech (NASDAQ: LEGN) was reported by Scotiabank on Wednesday, April 17, 2024. The analyst firm set a price target for 65.00 expecting LEGN to rise to within 12 months (a possible 40.72% upside). 33 analyst firms have reported ratings in the last year.

Current Stock Price for Legend Biotech (LEGN)?

The stock price for Legend Biotech (NASDAQ: LEGN) is $46.19 last updated Today at April 19, 2024 at 4:00 PM EDT.

Does Legend Biotech (LEGN) pay a dividend?

There are no upcoming dividends for Legend Biotech.

When is Legend Biotech (NASDAQ:LEGN) reporting earnings?

Legend Biotech’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Legend Biotech (LEGN) going to split?

There is no upcoming split for Legend Biotech.

What sector and industry does Legend Biotech (LEGN) operate in?

Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-